Navigation Links
Isis Pharmaceuticals to Present at the Stifel Nicolaus 2010 Healthcare Conference
Date:9/8/2010

CARLSBAD, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Stifel Nicolaus' 2010 Healthcare Conference on Thursday, September 16, 2010 at 8:35 a.m. ET at The Four Seasons Hotel in Boston, MA.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners.  The Company has successfully commercialized the world's first antisense drug and has 23 drugs in development.  Isis' drug development programs are focused on treating cardiovascular, metabolic, and severe neurodegenerative diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide.  Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment in Open-Label Trial and Completion of Treatment in QT Trial for LEVADEX™ Clinical Program
2. Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010
3. Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences
6. Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
7. Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification
8. Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
11. Pfizer to Acquire FoldRx Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015  Today, eight groups representing ... biologics – Alliance for Patient Access, American ... Rheumatology, Biologics Prescribers Collaborative, Clinical Immunology Society, ... and North American Society for Pediatric Gastroenterology, ... to U.S. Food and Drug Administration (FDA) ...
(Date:5/21/2015)... CITY and SEATTLE , ... leader in the development of robotics, sensors and medical ... as the company,s Chief Financial Officer and head ... of experience in corporate development, business development and finance ... Intellectual Ventures and Pendrell Corporation.  Mr. Woo will be ...
(Date:5/21/2015)... May 21, 2015 Increasing requirements, including ... made flat gaskets indispensable in the chemical and ... internal pressure pose major challenges to their performance. ... of three different materials whose scope covers the ... The white FG-360, based on DIN 28091-3, ...
Breaking Medicine Technology:Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 2Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 3Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 4Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2Flat gaskets for especially demanding applications in the processing industry 2
... , CLEVELAND, Dec. 16 ... services company focused on global eClinical solutions for the ... version 9.0 eClinical Software. This release advances the ... introduces two new mechanisms for facilitating DATATRAK ONE,s Knowledge(TM) ...
... , , , , ... at,deCODE genetics, Inc. (Nasdaq: DCGN ) publish in the journal Nature the,discovery ... human genome (SNP) with a major impact on susceptibility to type 2,diabetes ... unusual:,if an individual inherits it from their father, the variant increases risk ...
Cached Medicine Technology:DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4
(Date:5/22/2015)... 22, 2015 In efforts to offer ... section containing particular muscles stretches has been a large ... of stretches now complete, Chunk Fitness envisions a mid-June ... be filmed and released at a later point in ... here: http://www.chunkfitness.com/stretches . , About the Company: Chunk ...
(Date:5/22/2015)... May 22, 2015 Javon Bea ... be recognized for providing the highest quality emergency care ... health care decision-making,” said Javon R. Bea, President and ... commitment of our employee/partners to care for and respond ... Hospitals do not apply for this award, but are ...
(Date:5/22/2015)... Orlando, FL (PRWEB) May 22, 2015 ... United States and developmental projects in rural India. India ... most popular community projects that continues to help hundreds ... is pleased to sponsor a music concert by famous ... fundraise for the Hindu Society of Central Florida ...
(Date:5/21/2015)... May 21, 2015 Her popular Love Seminar ... Hilton Hotel in San Gabriel on Saturday, May 23rd. ... again from men and women who are unhappy in their ... partner." , "Many singles think that their biggest problem is ... would go from one relationship to another trying to find ...
(Date:5/21/2015)... CA (PRWEB) May 21, 2015 Absolute ... has a highly interactive, state-of-the-art website that is filled ... latest trade show resource information. With its original and ... well as practical. The website shows hundred of pictures ... trade show floor. This is not an exhibit rendering ...
Breaking Medicine News(10 mins):Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:India Network Visitor Health Insurance Announces Corporate Sponsorship of Anuradha Paudwal Musical in Orlando to Help Fundraise for Hindu Society of Central Florida. 2Health News:Bestselling Author Sheds Light on Why Modern Dating is Hurting People's Chances of Finding a Lasting Relationship 2Health News:New Convention and City Travel Guides Within the Absolute Exhibits’ Website 2
... returned sound to young adults with acoustic neuromas , FRIDAY, ... no longer hear her mother,s voice or the sound of ... earlier, Garrett learned she had neurofibromatosis type 2 (NF2), a ... tumors, acoustic neuromas, damaged the eighth cranial nerve in one ...
... , DETROIT, Sept. 11 United American Healthcare ... its financial results for the fourth fiscal quarter and full year ... close. The Company expects to file its Form 10-K for ... (SEC) on a timely basis in compliance with applicable regulations. ...
... that are now emerging from various clinical trials of ... We expect additional companies to announce their preliminary trial ... that 2009 H1N1 influenza vaccines are well tolerated and ... when administered in a single unadjuvanted 15-microgram dose. We ...
... treatment, researchers say , FRIDAY, Sept. 11 (HealthDay News) ... to develop the most common form of the autoimmune ... it, new research shows. , Lupus, also known ... that often affects the joints, kidneys, blood and nervous ...
... The U.S. Food and Drug Administration today released ... articles can be accessed from the agency,s Web page ... can sign-up for e-mail notices of new consumer updates ... https://service.govdelivery.com/service/subscribe.html?code=USFDA_9 . An RSS feed is also ...
... hard-of-hearing may benefit from electronic assistance, researchers say , ... lips better than people can, new research suggests. , ... the deaf and hard-of-hearing learn to read lips, according ... England. , Researchers compared the accuracy of an automated ...
Cached Medicine News:Health News:Cancer Drug Shrinks Benign Tumors That Steal Hearing 2Health News:Cancer Drug Shrinks Benign Tumors That Steal Hearing 3Health News:United American Healthcare Corporation Announces Release Date for Fiscal 2009 Fourth Quarter and Full Year Results 2Health News:Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 2Health News:Lupus Worse in Blacks, Hispanics Than in Whites, Study Finds 2Health News:FDA Consumer Health Information Updates 2Health News:FDA Consumer Health Information Updates 3Health News:Computers Might Make Learning Lip Reading Easier 2
Fine .12mm Tip With 5mm Platform; In Titanium....
45 Degree Angle With 0.3, 12 Teeth with 5mm Tying Platform; In Titanium....
Curved 30mm shaft (in stainless steel); rubber coated for safer use; includes 1.5 meter cable and connectors....
0.3mm tips; 9.5mm from tips to cross action; in Titanium....
Medicine Products: